Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly

Respiratory syncytial virus (RSV) is a significant threat to elderly populations and repeated infections that occur throughout life are poorly protective. To assess the role of prior RSV infections as well as elderly immune senescence on vaccine efficacy, we compared immune responses after virus-lik...

Full description

Bibliographic Details
Main Authors: Jorge C. G. Blanco, Lori M. Cullen, Arash Kamali, Fatouomata Y. D. Sylla, Marina S. Boukhvalova, Trudy G. Morrison
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/6/1305
_version_ 1797592396099223552
author Jorge C. G. Blanco
Lori M. Cullen
Arash Kamali
Fatouomata Y. D. Sylla
Marina S. Boukhvalova
Trudy G. Morrison
author_facet Jorge C. G. Blanco
Lori M. Cullen
Arash Kamali
Fatouomata Y. D. Sylla
Marina S. Boukhvalova
Trudy G. Morrison
author_sort Jorge C. G. Blanco
collection DOAJ
description Respiratory syncytial virus (RSV) is a significant threat to elderly populations and repeated infections that occur throughout life are poorly protective. To assess the role of prior RSV infections as well as elderly immune senescence on vaccine efficacy, we compared immune responses after virus-like particle (VLP) immunization of elderly cotton rats and young cotton rats, both previously RSV infected, in order to mimic the human population. We show that immunization of RSV-experienced young or elderly animals resulted in the same levels of anti-pre-F IgG, anti-G IgG, neutralizing antibody titers, and protection from challenge indicating that the delivery of F and G proteins in a VLP is equally effective in activation of protective responses in both elderly and young populations. Our results suggest that F and G protein-containing VLPs induce anti-RSV memory established in prior RSV infections equally well in both young and elderly animals and thus can be an effective vaccine for the elderly.
first_indexed 2024-03-11T01:50:25Z
format Article
id doaj.art-ce843923b5b84c6f969e9a2b6a6b1bd9
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T01:50:25Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-ce843923b5b84c6f969e9a2b6a6b1bd92023-11-18T13:01:54ZengMDPI AGViruses1999-49152023-05-01156130510.3390/v15061305Development of Respiratory Syncytial Virus Vaccine Candidates for the ElderlyJorge C. G. Blanco0Lori M. Cullen1Arash Kamali2Fatouomata Y. D. Sylla3Marina S. Boukhvalova4Trudy G. Morrison5Sigmovir Biosystems Inc., Rockville, MD 20850, USADepartment of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01655, USASigmovir Biosystems Inc., Rockville, MD 20850, USASigmovir Biosystems Inc., Rockville, MD 20850, USASigmovir Biosystems Inc., Rockville, MD 20850, USADepartment of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01655, USARespiratory syncytial virus (RSV) is a significant threat to elderly populations and repeated infections that occur throughout life are poorly protective. To assess the role of prior RSV infections as well as elderly immune senescence on vaccine efficacy, we compared immune responses after virus-like particle (VLP) immunization of elderly cotton rats and young cotton rats, both previously RSV infected, in order to mimic the human population. We show that immunization of RSV-experienced young or elderly animals resulted in the same levels of anti-pre-F IgG, anti-G IgG, neutralizing antibody titers, and protection from challenge indicating that the delivery of F and G proteins in a VLP is equally effective in activation of protective responses in both elderly and young populations. Our results suggest that F and G protein-containing VLPs induce anti-RSV memory established in prior RSV infections equally well in both young and elderly animals and thus can be an effective vaccine for the elderly.https://www.mdpi.com/1999-4915/15/6/1305respiratory syncytial virusvaccinevirus-like particleimmunity
spellingShingle Jorge C. G. Blanco
Lori M. Cullen
Arash Kamali
Fatouomata Y. D. Sylla
Marina S. Boukhvalova
Trudy G. Morrison
Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
Viruses
respiratory syncytial virus
vaccine
virus-like particle
immunity
title Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
title_full Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
title_fullStr Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
title_full_unstemmed Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
title_short Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
title_sort development of respiratory syncytial virus vaccine candidates for the elderly
topic respiratory syncytial virus
vaccine
virus-like particle
immunity
url https://www.mdpi.com/1999-4915/15/6/1305
work_keys_str_mv AT jorgecgblanco developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly
AT lorimcullen developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly
AT arashkamali developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly
AT fatouomataydsylla developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly
AT marinasboukhvalova developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly
AT trudygmorrison developmentofrespiratorysyncytialvirusvaccinecandidatesfortheelderly